{"name":"Friederike Holze","slug":"friederike-holze","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LSD 10 μg every other day","genericName":"LSD 10 μg every other day","slug":"lsd-10-g-every-other-day","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"LSD 10 μg every other day","genericName":"LSD 10 μg every other day","slug":"lsd-10-g-every-other-day","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA5cUIxWTAxcmFlbVBES3ZoQktrdExkRGdEUXVVQUdFVERiUFB2QWo1MzFiZ3c4c2RvZzlyQmpjb2EtV2VUdTNZajFRRnRUVGRTejJPbEhhZGpYNTZkWlZN?oc=5","date":"2022-02-25","type":"trial","source":"nature.com","summary":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology - nature.com","headline":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIOGNZVERaMGdNNXBBRUthY2o1UF9wV1ZRUzJzY25KN1IxWlZTYlB1ZmZMcTFLX1BuN0Z4V2lkY3NYQzJpWjZLLXVzZUxrczNlMV84SE1sQ1B3V3hXUWJJ?oc=5","date":"2020-10-15","type":"trial","source":"nature.com","summary":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology - nature.com","headline":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subject","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}